BTIG raised the firm’s price target on HealthEquity to $100 from $85 and keeps a Buy rating on the shares. The analyst cites the company’s year-end sales data showing “impressive results”, strengthening its position in the HSA market. BTIG adds it is positive on HealthEquity seeking to create a digital card that can go into a digital wallet, the pricing solution that shows how much certain procedures cost by various providers in certain zip codes, and its heavy investment into automating various member services solutions that can automate many processes.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HQY:
- HealthEquity Reports Year-End Sales Metrics
- HealthEquity price target raised to $93 from $85 at BofA
- HealthEquity Recognized by Glassdoor as a Top U.S. Workplace for 2024
- Wells says key metrics tracking ahead as HealthEquity provides sales outlook
- HealthEquity Announces Year-End HSA Sales Outlook; Presentation at J.P. Morgan Healthcare Conference; Investor Day
